Psychosis Risk (AKA attenuated psychotic symptoms disorder) has always had three strikes against it:
1) A ridiculously high false positive rate of 70-90%
2) No treatment of proven efficacy
3) Terrible risks of antipsychotic side effects and stigma.
Now there are three additional new strikes:
1) Recent publications in the American Journal of Psychiatry further document the pitfalls of the proposed diagnosis and explicitly advise against its inclusion in DSM 5.
2) Withdrawal of support for DSM 5 inclusion from two of its previous strongest backers- pioneers in this field of research, Patrick McGorry and Alison Yung. They join many other researchers in the early intervention field who care a great deal about helping to reduce the burdens of schizophrenia, but recognize that the DSM 5 psychosis risk proposal is a premature and fatally flawed means to this end.